Relapse
Relapse
Explore linked clinical trials. Standard reference: MESH:M001866329 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC | Disease Attributes, Head and Neck Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, head and neck cancer, neoplasm, refractory malignant neoplasm | Recruiting | Phase 1 | 2026-09-16 | NCT06096038 | |
| Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, acute myeloid leukemia, graft versus host disease, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Not stated | 2026-08-13 | NCT07570407 | |
| ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells | Disease Attributes, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-08-06 | NCT06090864 | |
| To Explore the Influencing Factors and Solutions for Patients With Plaque Psoriasis Undergoing Relapse | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse | Active, not recruiting | Not stated | 2026-07-28 | NCT07730619 | |
| Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells | Disease Attributes, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, refractory malignant neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 1 | 2026-07-28 | NCT06347068 | |
| Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool | Alcohol Use Disorder, Chemically-Induced Disorders, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, alcohol withdrawal, alcohol-related disorders, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-06-18 | NCT06618755 | |
| Isa-Pom-Dex in Elderly/Frail Subjects With RRMM | Blood Protein Disorders, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2026-06-09 | NCT05911321 | |
| Autologous CAR-T Cells Targeting B7-H3 in PDAC | Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, refractory malignant neoplasm | Recruiting | Phase 1 | 2026-06-08 | NCT06158139 | |
| Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM | Blood Protein Disorders, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2026-06-08 | NCT04176718 | |
| Comparative 3-dimensional Superimposition Analysis of Dentition in Horizontal and Vertical Grower During the Retention Phase -A Prospective Clinical Trial'' | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse | Recruiting | Not applicable | 2026-06-03 | NCT07622277 | |
| Multi-Omics Inflammatory Phenotype for ABPA Recurrence Risk Prediction | Bacterial Infections and Mycoses, Disease Attributes, Hypersensitivity, Immediate, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, Respiratory Hypersensitivity, allergic bronchopulmonary aspergillosis, aspergillosis, fungal infectious disease, fungal lung infectious disease, immune system disorder, lung disorder, pulmonary aspergilloma, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not stated | 2026-06-01 | NCT07611838 | |
| A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant Chemotherapy | Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 2 | 2026-05-22 | NCT07604909 | |
| Study of the Impact on the Evolution of the Disease in the Medium Term of the Implementation of a System of Extended Follow-up by Telephone Interview of Patients With an Eating Disorder Organized by the Nurses of the Eating Disorder Referral Center | Disease Attributes, Eating Disorders, Feeding and Eating Disorders, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, Signs and Symptoms, Signs and Symptoms, Digestive, psychiatric disorder | Active, not recruiting | Not stated | 2026-05-06 | NCT04864626 | |
| EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases | Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Not yet recruiting | Not stated | 2026-03-04 | NCT07448376 | |
| Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, large B-cell lymphoma | Recruiting | Phase 2 | 2026-03-02 | NCT06919939 | |
| The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia | Bone Marrow Failure Disorders, Disease Attributes, Hemic and Lymphatic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, anemia, aplastic anemia, bone marrow disorder, hematologic disorder | Not yet recruiting | Phase 1 / Phase 2 | 2025-12-17 | NCT07287228 | |
| Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta) | Disease Attributes, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 1 | 2025-10-31 | NCT00368082 | |
| IA Carboplatin + Radiotherapy in Relapsing GBM | Disease Attributes, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 / Phase 2 | 2025-08-11 | NCT03672721 | |
| Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma | Disease Attributes, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2025-08-07 | NCT06356883 | |
| Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, hematologic disorder, leukemia, neoplasm | Recruiting | Phase 2 | 2025-08-06 | NCT07105579 | |
| CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia | Bone Marrow Failure Disorders, Disease Attributes, Hemic and Lymphatic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, anemia, aplastic anemia, bone marrow disorder, hematologic disorder | Recruiting | Phase 1 | 2025-07-24 | NCT06622694 | |
| Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Recurrence, Relapse, T-cell acute lymphoblastic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2025-05-07 | NCT06686108 | |
| Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder | Alcohol Use Disorder, Chemically-Induced Disorders, Disease Attributes, Fractures, Stress, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, alcohol abuse, alcohol-related disorders, bone fracture, injury, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2025-04-29 | NCT06105853 | |
| Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2025-02-24 | NCT06737523 | |
| Azacitidine Combined with Donor Lymphocyte Infusion for Acute Myeloid Leukemia Post-transplant Relapse Prevention. | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Not yet recruiting | Phase 2 | 2025-01-17 | NCT06754540 |